These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

859 related items for PubMed ID: 24285003

  • 1. Treatment of ulcerative colitis.
    Blonski W, Buchner AM, Lichtenstein GR.
    Curr Opin Gastroenterol; 2014 Jan; 30(1):84-96. PubMed ID: 24285003
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Medical therapy of inflammatory bowel diseases: ulcerative colitis].
    Lakatos L, Lakatos PL.
    Orv Hetil; 2007 Jun 24; 148(25):1163-70. PubMed ID: 17573252
    [Abstract] [Full Text] [Related]

  • 5. New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
    Eliadou E, Day AS, Thompson-Fawcett MW, Gearry RB, Rowbotham DS, Walmsley R, Schultz M, Inns SJ, IBDNZ, New Zealand Society of Gastroenterology.
    N Z Med J; 2015 Oct 16; 128(1423):63-76. PubMed ID: 26645757
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evolving medical therapies for ulcerative colitis.
    Cohen RD.
    Curr Gastroenterol Rep; 2002 Dec 16; 4(6):497-505. PubMed ID: 12441040
    [Abstract] [Full Text] [Related]

  • 12. Treatment of ulcerative colitis.
    Ludwig D, Stange EF.
    Hepatogastroenterology; 2000 Dec 16; 47(31):83-9. PubMed ID: 10690588
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Golimumab for moderately to severely active ulcerative colitis.
    Kedia S, Ahuja V, Makharia GK.
    Expert Rev Clin Pharmacol; 2016 Oct 16; 9(10):1273-82. PubMed ID: 27498886
    [Abstract] [Full Text] [Related]

  • 16. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun 16; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 17. [Management of ulcerative colitis].
    Rammert Ch, Kullak-Ublick GA.
    Ther Umsch; 2003 Mar 16; 60(3):145-50. PubMed ID: 12693317
    [Abstract] [Full Text] [Related]

  • 18. Conventional medical management of inflammatory bowel disease.
    Burger D, Travis S.
    Gastroenterology; 2011 May 16; 140(6):1827-1837.e2. PubMed ID: 21530749
    [Abstract] [Full Text] [Related]

  • 19. Clinical experience with adalimumab in anti-TNF-naïve patients with ulcerative colitis.
    Busquets D, Aldeguer X.
    J Crohns Colitis; 2013 Jun 16; 7(5):e195. PubMed ID: 23219261
    [No Abstract] [Full Text] [Related]

  • 20. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec 16; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.